Sartorius Stedim Biotech announces its capital structure and voting rights for March 2024

Sartorius Stedim Biotech SA has made public the figures relating to its share capital and voting rights as of March 31, 2024. According to this regulatory declaration, the company's share capital is made up of 97,330,405 shares. In addition, the total number of theoretical voting rights stands at 165,579,864, while the net voting rights reach 165,563,706.

This information is published in accordance with article L 233-8-II of the Commercial Code and article 223-6 of the AMF general regulations. The disclosure of data aims to maintain transparency with shareholders and the market regarding the structure of the company.